WASHINGTON — Pharmaceutical large AbbVie paid well being care suppliers roughly $145.7 million final 12 months to advertise its medication, in line with a STAT evaluation of newly launched authorities knowledge.
The huge sum spent by AbbVie, the maker of the mega blockbuster anti-inflammatory drug Humira, is essentially the most a pharmaceutical firm has spent on advertising to medical doctors since such knowledge turned out there in 2017. The determine contains compensation for consulting and different providers like talking charges, lodging and journey for medical doctors, and meals, in addition to a small variety of funds made on to hospitals.
The funds, made public by the Facilities for Medicare and Medicaid Companies, present an perception into AbbVie’s advertising within the fast aftermath of the corporate dropping its monopoly on Humira, which dominated the corporate’s steadiness sheets for the higher a part of the final 20 years. The funds present that the corporate is being way more aggressive in concentrating on medical doctors than rivals of comparable measurement.
This text is unique to STAT+ subscribers
Unlock this text — plus in-depth evaluation, newsletters, premium occasions, and networking platform entry.
Have already got an account? Log in
Have already got an account? Log in
View All Plans